134 related articles for article (PubMed ID: 10767071)
1. MR contrast agents in acute experimental cerebral ischemia: potential adverse impacts on neurologic outcome and infarction size.
Doerfler A; Engelhorn T; Heiland S; Knauth M; Wanke I; Forsting M
J Magn Reson Imaging; 2000 Apr; 11(4):418-24. PubMed ID: 10767071
[TBL] [Abstract][Full Text] [Related]
2. Comparison of USPIO-enhanced MRI and Gd-DTPA enhancement during the subacute stage of focal cerebral ischemia in rats.
Yang YM; Feng X; Yin le K; Li CC; Jia J; Du ZG
Acta Radiol; 2014 Sep; 55(7):864-73. PubMed ID: 24065200
[TBL] [Abstract][Full Text] [Related]
3. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
[TBL] [Abstract][Full Text] [Related]
4. Are iodinated contrast agents detrimental in acute cerebral ischemia? An experimental study in rats.
Doerfler A; Engelhorn T; von Kummer R; Weber J; Knauth M; Heiland S; Sartor K; Forsting M
Radiology; 1998 Jan; 206(1):211-7. PubMed ID: 9423675
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of magnetite as an MRI contrasting agent in an experimental cerebral ischemic model. Evaluation of lesion detecting time].
Hisakane M; Katayama Y; Igarashi H; Terashi A
Nihon Ika Daigaku Zasshi; 1998 Jun; 65(3):201-6. PubMed ID: 9656703
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dysprosium DTPA BMA and superparamagnetic iron oxide particles as susceptibility contrast agents for perfusion imaging of regional cerebral ischemia in the rat.
Haraldseth O; Jones RA; Müller TB; Fahlvik AK; Oksendal AN
J Magn Reson Imaging; 1996; 6(5):714-7. PubMed ID: 8890008
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
[TBL] [Abstract][Full Text] [Related]
8. MRI in acute cerebral ischaemia: perfusion imaging with superparamagnetic iron oxide in a rat model.
Forsting M; Reith W; Dörfler A; von Kummer R; Hacke W; Sartor K
Neuroradiology; 1994; 36(1):23-6. PubMed ID: 8107990
[TBL] [Abstract][Full Text] [Related]
9. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
Simon GH; von Vopelius-Feldt J; Wendland MF; Fu Y; Piontek G; Schlegel J; Chen MH; Daldrup-Link HE
J Magn Reson Imaging; 2006 May; 23(5):720-7. PubMed ID: 16557494
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of experimental early acute cerebral ischemia before the development of edema: use of dynamic, contrast-enhanced and diffusion-weighted MR scanning.
Finelli DA; Hopkins AL; Selman WR; Crumrine RC; Bhatti SU; Lust WD
Magn Reson Med; 1992 Sep; 27(1):189-97. PubMed ID: 1435205
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
12. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
13. Neurotolerability of contrast agents in rats with brain ischemia induced by transient middle cerebral artery occlusion: EEG evaluation.
Frigeni V; Miragoli L; Grotti A; Lorusso V
Invest Radiol; 2001 Jan; 36(1):1-8. PubMed ID: 11176255
[TBL] [Abstract][Full Text] [Related]
14. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats.
Knight RA; Barker PB; Fagan SC; Li Y; Jacobs MA; Welch KM
Stroke; 1998 Jan; 29(1):144-51. PubMed ID: 9445344
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data.
Sharma R; Saini S; Ros PR; Hahn PF; Small WC; de Lange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK; Morris M; Lucas M
J Magn Reson Imaging; 1999 Feb; 9(2):291-4. PubMed ID: 10077027
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.
Hamm B; Staks T; Taupitz M; Maibauer R; Speidel A; Huppertz A; Frenzel T; Lawaczeck R; Wolf KJ; Lange L
J Magn Reson Imaging; 1994; 4(5):659-68. PubMed ID: 7981510
[TBL] [Abstract][Full Text] [Related]
17. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
18. CBF and CBV measurements by USPIO bolus tracking: reproducibility and comparison with Gd-based values.
Simonsen CZ; Ostergaard L; Vestergaard-Poulsen P; Røhl L; Bjørnerud A; Gyldensted C
J Magn Reson Imaging; 1999 Feb; 9(2):342-7. PubMed ID: 10077035
[TBL] [Abstract][Full Text] [Related]
19. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
[TBL] [Abstract][Full Text] [Related]
20. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
